Jane Street’s Genetic Technologies Ltd. GENE Stock Holding History

Jane Street’s Portfolio GENE Stock Details GENE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-3,472	Closed	-$74K	–	10956
2021 Q2	$74K	Buy	+3,472	New	+$70K	﹤0.01%	9390
2019 Q3	–	Sell	-502	Closed	-$6K	–	5920
2019 Q2	$6K	Buy	+502	New	+$7.72K	﹤0.01%	5052
2018 Q4	–	Sell	-677	Closed	-$15K	–	5913
2018 Q3	$15K	Buy	677 +38	+6%	+$863	﹤0.01%	4983
2018 Q2	$13K	Sell	639 -37	-5%	-$875	﹤0.01%	4877
2018 Q1	$14K	Buy	+676	New	+$19.5K	﹤0.01%	4722
2016 Q1	–	Sell	-972	Closed	-$52K	–	4762
2015 Q4	$52K	Buy	+972	New	+$49K	﹤0.01%	3870
2015 Q2	–	Sell	-674	Closed	-$71K	–	4153
2015 Q1	$71K	Buy	+674	New	+$55.1K	﹤0.01%	3026
2014 Q4	–	Sell	-147	Closed	-$8K	–	3146
2014 Q3	$8K	Buy	+147	New	+$11.5K	﹤0.01%	2481

Other funds holding GENE

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

RBC Europe London, United Kingdom $2.08B AUM 12.2% 1-Year Est. Return

Jane Street's GENE Position: Q3 2021 in Review

Jane Street sold out of Genetic Technologies Ltd. (GENE) in Q3 2021, closing a stake of 3,472 shares — an estimated $74K sold.

Jane Street first reported a position in GENE in Q3 2014 and held it in 8 quarters. The position peaked at $74K in Q2 2021. 12 funds tracked by Wall St. Rank hold GENE as of Q3 2021.

Jane Street reported no remaining Genetic Technologies Ltd. position as of Q3 2021 after selling out during the quarter.
Jane Street sold 3,472 Genetic Technologies Ltd. shares in Q3 2021, an estimated $74K.
Jane Street first reported a position in Genetic Technologies Ltd. in Q3 2014 and held it in 8 quarters.
Jane Street's Genetic Technologies Ltd. position peaked at $74K in Q2 2021.
12 funds tracked by Wall St. Rank held Genetic Technologies Ltd. as of Q3 2021.

Based on Jane Street's 13F filing for Q3 2021, filed 16 Nov 2021.